- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Philadelphia Chromosome Positive
Total 6751 results
-
Novartis PharmaceuticalsCompletedPhiladelphia Chromosome Positive Chronic Myelogenous LeukemiaGermany, Canada, France, Spain, Italy
-
Novartis PharmaceuticalsCompletedPhiladelphia Chromosome Positive CMLUnited States, Germany, Italy, France
-
PETHEMA FoundationTerminatedPhiladelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALLSpain
-
Goethe UniversityCompletedPhiladelphia Chromsome Positive Acute Lymphoblastic LeukemiaSpain, Germany, France
-
Merck Sharp & Dohme LLCTerminatedBlast Phase Philadelphia Chromosomes Positive (Ph+) Chronic Myelogenous Leukemia (CML) | Philadelphia Chromosome Positive (Ph+) Acute Lymphocytic Leukemia (ALL)
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingALL, Adult | Philadelphia-Positive ALL | Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)Italy
-
OHSU Knight Cancer InstituteAriad PharmaceuticalsNo longer availableChronic Myeloid Leukemia | Philadelphia Chromosome Positive (Ph+) LeukemiasUnited States
-
The University of Hong KongUnknownChronic Myeloid Leukemia | Philadelphia Chromosome Positive CMLHong Kong
-
Rambam Health Care CampusMiltenyi Biomedicine GmbHUnknownPhiladelphia Chromosome-positive Chronic Myelocytic LeukemiaIsrael
-
Centre Leon BerardActive, not recruitingPhiladelphia Chromosome Positive CML | BCR-ABL Positive Chronic Myelogenous LeukemiaFrance
-
Hikma Pharmaceuticals LLCCompletedPhiladelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic PhaseEgypt
-
Novartis PharmaceuticalsCompletedPhiladelphia Chromosome Positive | Chronic Myelogenous Leukemia in Chronic PhaseJapan
-
PfizerCompletedPhiladelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia (CML)Singapore
-
Renato MelaragnoUnknownChronic Myeloid Leukemia (CML) With Philadelphia Chromosome-positive (Ph+)Brazil
-
Bristol-Myers SquibbCompletedMyeloid Leukemia, ChronicJapan
-
Novartis PharmaceuticalsActive, not recruitingChronic Myeloid Leukemia (CML) Philadelphia Chromosome PositiveUnited States, China, Hungary, Japan, Belgium, Germany, Canada, Singapore, Australia, Israel, Netherlands, Spain, Italy, Korea, Republic of, Bulgaria, France, United Kingdom, Czechia, Sweden, India, Malaysia, Denmark, Taiwan, Norway, Fi... and more
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Philadelphia-Positive Myeloid LeukemiaBelgium, Netherlands, Spain, United States, Italy, Canada, France, Germany, Peru, Singapore, United Kingdom, Australia, Sweden, Finland, Israel, Ireland, Denmark, Korea, Republic of, Norway, Austria, South Africa, Switzerland
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Philadelphia-Positive Myeloid LeukemiaBelgium, Spain, United States, Italy, Argentina, Brazil, Canada, Germany, Peru, Puerto Rico, Singapore, South Africa, Taiwan, United Kingdom, Australia, France, Philippines, Sweden, Thailand, Russian Federation, China, Poland, Finland, Isra... and more
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous LeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingPhiladelphia Chromosome Positive | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | CD19 PositiveUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingPhiladelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous LeukemiaUnited States
-
Novartis PharmaceuticalsRecruitingPhiladelphia Chromosome-Positive Chronic Myeloid LeukemiaSingapore, France, Germany, United Arab Emirates, Greece, Italy, Czechia, Hungary, United States, India, Oman, Malaysia, Korea, Republic of, Turkey, Bulgaria, Canada, Slovakia, United Kingdom, Argentina, Jordan, Romania, South Africa and more
-
Crystal Mackall, MDCalifornia Institute for Regenerative Medicine (CIRM)Active, not recruitingB Acute Lymphoblastic Leukemia | Philadelphia Chromosome Positive | Minimal Residual Disease | CD19 PositiveUnited States
-
Novartis PharmaceuticalsCompletedPhiladelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)Germany, Belgium, France, Italy, Spain, Hungary, Austria, Sweden, Bulgaria, Denmark, Greece, Slovenia, United Kingdom, Czechia, Romania, Serbia, Slovakia, Portugal, Finland, Norway, Poland
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous LeukemiaUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsNot yet recruitingAcute Lymphoblastic Leukemia | Philadelphia Chromosome-PositiveUnited States
-
Institute of Hematology & Blood Diseases Hospital...RecruitingPhiladelphia Chromosome Positive Acute Lymphoblastic LeukemiaChina
-
Memorial Sloan Kettering Cancer CenterAmgenActive, not recruitingAcute Lymphoblastic Leukemia | Philadelphia Chromosome-PositiveUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedMinimal Residual Disease | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive in RemissionUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Astex Pharmaceuticals, Inc.RecruitingChronic Phase Chronic Myelogenous Leukemia | Philadelphia Chromosome Positive | BCR-ABL1 Positive Chronic Myelogenous Leukemia | BCR-ABL1 PositiveUnited States
-
Goethe UniversityGerman Federal Ministry of Education and Research; Deutsche Leukämie- & Lymphom-HilfeRecruitingPhiladelphia Chromosome Positive Acute Lymphoblastic LeukemiaGermany
-
Assistance Publique - Hôpitaux de ParisRecruitingPhiladelphia Chromosome Positive Adult Acute Lymphoblastic LeukemiaFrance
-
Novartis PharmaceuticalsCompletedPhiladelphia Chromosome Positive Acute Lymphocytic Leukemia
-
TakedaActive, not recruitingPediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL) | Ph+ Mixed Phenotype Acute Leukemia (MPAL) | Philadelphia Chromosome-Like ALL (Ph-like ALL)United States, France, Korea, Republic of, China, Spain, United Kingdom, Czechia, Portugal, Brazil, Argentina, Italy, Australia, Mexico, Netherlands, Poland
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous LeukemiaUnited States
-
Novartis PharmaceuticalsRecruitingMyeloid Leukemia, Philadelphia PositiveChina, Korea, Republic of, Germany, France, United States, Greece, Hungary, Italy, Japan, Poland, Russian Federation, Thailand, Turkey, Netherlands
-
Novartis PharmaceuticalsTerminatedCML | Philadelphia Chromosome Positive (Ph+) | Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib Trough LevelsUnited States
-
TakedaActive, not recruitingPhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)United States, China, Spain, Australia, Canada, Argentina, Korea, Republic of, Brazil, Japan, Italy, Mexico, France, Greece, Poland, Russian Federation, Austria, Taiwan, Bulgaria, Finland, Turkey
-
Brian JonasNational Cancer Institute (NCI); Pharmacyclics LLC.RecruitingPhiladelphia Chromosome Positive | Adult B Acute Lymphoblastic LeukemiaUnited States
-
Renato MelaragnoSuspendedAcute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)
-
Korea Otsuka Pharmaceutical Co., Ltd.Active, not recruitingChronic Myeloid Leukemia | Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaKorea, Republic of
-
National Cancer Institute (NCI)TerminatedRecurrent Adult Acute Lymphoblastic Leukemia | Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); ADC Therapeutics S.A.RecruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Philadelphia Chromosome Positive | Blasts 5 Percent or More of Bone Marrow Nucleated Cells | CD22 PositiveUnited States
-
Goethe UniversityCompletedPhiladelphia Positive Acute Lymphoblastic LeukemiaGermany
-
Nanfang Hospital of Southern Medical UniversityGuangxi Medical University; Peking University People's Hospital; Sun Yat-Sen... and other collaboratorsUnknownStem Cell Transplantation | Minimal Residual Disease | Philadelphia Chromosome Positive Acute Lymphocytic LeukemiaChina
-
Ariad PharmaceuticalsCompletedChronic Myeloid Leukemia (CML) | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)Japan
-
Ariad PharmaceuticalsApproved for marketingChronic Myeloid Leukemia (CML) | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)United States
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Leukemia, Lymphoblastic, Acute, Philadelphia-positiveNetherlands, United States, Italy, Argentina, Austria, Brazil, Canada, Germany, Peru, United Kingdom, France, Korea, Republic of, Sweden, Finland, Australia, Israel, Belgium, Denmark, Norway, Switzerland
-
Incyte Biosciences BeneluxCompletedChronic Myeloid Leukemia | CML | Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia | Ph+ ALLBelgium
-
Bristol-Myers SquibbCompletedChronic Myelogenous Leukemia | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia